These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 158450)

  • 1. Selective defects in T cell function in ataxia-telangiectasia.
    Levis WR; Dattner AM; Shaw JS
    Clin Exp Immunol; 1979 Jul; 37(1):44-9. PubMed ID: 158450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
    Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
    J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective specific antiinfluenza virus antibody production in vitro by lymphocytes from patients with ataxia-telangiectasia.
    Yarchoan R; Kurman CC; Nelson DL
    Kroc Found Ser; 1985; 19():315-29. PubMed ID: 3877788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases.
    Mawas C; Sasportes M; Charmot D; Christen Y; Dausset J
    Clin Exp Immunol; 1975 Apr; 20(1):83-92. PubMed ID: 128428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CD3 antigen expression in patients with ataxia-telangiectasia.
    Boutin B; Wagner DK; Nelson DL
    Clin Exp Immunol; 1987 May; 68(2):320-30. PubMed ID: 3115644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective activation of the alternative pathway of complement in two brothers with ataxia-telangiectasia.
    Saint-Remy JM; Dent RG; Cole P
    J Clin Lab Immunol; 1981 Nov; 6(3):221-6. PubMed ID: 7338883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low thymic output and reduced heterogeneity of alpha/beta, but not gamma/delta, T lymphocytes in infants with ataxia-telangiectasia.
    Micheli R; Pirovano S; Calandra G; Valotti M; Plebani A; Albertini A; Imberti L
    Neuropediatrics; 2003 Jun; 34(3):165-7. PubMed ID: 12910443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members.
    Lahat N; Zelnik N; Froom P; Kinarty A; Etzioni A
    Clin Exp Immunol; 1988 Oct; 74(1):32-5. PubMed ID: 2851398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
    Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
    Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis.
    Evans RL; Lazarus H; Penta AC; Schlossman SF
    J Immunol; 1978 Apr; 120(4):1423-8. PubMed ID: 147908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the LFA-1 molecule in cellular interactions required for antibody production in humans.
    Fischer A; Durandy A; Sterkers G; Griscelli C
    J Immunol; 1986 May; 136(9):3198-203. PubMed ID: 3514755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective allosuppression in patients with ataxia-telangiectasia.
    Tosato G; Blaese RM
    Kroc Found Ser; 1985; 19():331-8. PubMed ID: 2999344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastogenic factor: its role in the mixed leukocyte culture reaction.
    Uotila M; Rode HN; Gordon J
    Eur J Immunol; 1978 Feb; 8(2):133-8. PubMed ID: 149007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human intestinal mononuclear cells. II. Demonstration of a naturally occurring subclass of T cells which respond in the allogeneic mixed leukocyte reaction but do not effect cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Jenkins KM; Franklin GO; Shedlofsky S; Kodner IJ
    Gastroenterology; 1981 Apr; 80(4):748-57. PubMed ID: 6451470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intact T cell responses in ataxia telangiectasia.
    Pashankar F; Singhal V; Akabogu I; Gatti RA; Goldman FD
    Clin Immunol; 2006 Aug; 120(2):156-62. PubMed ID: 16762595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.